We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $14.2B
1-Year Est. Return 24.58%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+24.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
Cap. Flow
+$589M
Cap. Flow %
4.16%
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$134M
2
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$120M
3
KKR icon
KKR & Co
KKR
+$113M
4
MDLZ icon
Mondelez International
MDLZ
+$103M
5
AXS icon
AXIS Capital
AXS
+$97.1M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$303M
2
BSX icon
Boston Scientific
BSX
+$127M
3
LEN icon
Lennar Class A
LEN
+$95.9M
4
MLM icon
Martin Marietta Materials
MLM
+$94.6M
5
CL icon
Colgate-Palmolive
CL
+$92M

Sector Composition

Rank Sector Weight
1 Financials 16.98%
2 Technology 14.39%
3 Industrials 12.27%
4 Healthcare 11.72%
5 Consumer Discretionary 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESAB icon
501
ESAB
ESAB
$5.33B
$887K 0.01%
9,176
+5,720
+166% +$663K
BDC icon
502
Belden
BDC
$4.05B
$882K 0.01%
7,684
+1,962
+34% +$247K
GSHD icon
503
Goosehead Insurance
GSHD
$1.23B
$879K 0.01%
20,599
-167,672
-89% -$9.38M
NUE icon
504
Nucor
NUE
$53.7B
$869K 0.01%
+5,137
New +$895K
TRIP icon
505
TripAdvisor
TRIP
$1.6B
$867K 0.01%
+81,374
New +$948K
MOS icon
506
The Mosaic Company
MOS
$7.29B
$841K 0.01%
32,965
-69,545
-68% -$1.91M
CALM icon
507
Cal-Maine
CALM
$4.12B
$838K 0.01%
10,592
-4,230
-29% -$347K
BANF icon
508
BancFirst
BANF
$3.86B
$837K 0.01%
+7,712
New +$857K
DCI icon
509
Donaldson
DCI
$10.5B
$827K 0.01%
+9,739
New +$941K
PCRX icon
510
Pacira BioSciences
PCRX
$1.01B
$823K 0.01%
36,422
-410
-1% -$9.11K
UPBD icon
511
Upbound Group
UPBD
$1.27B
$818K 0.01%
45,314
+26,152
+136% +$510K
ZBRA icon
512
Zebra Technologies
ZBRA
$12.6B
$812K 0.01%
3,883
+2,227
+134% +$523K
CRUS icon
513
Cirrus Logic
CRUS
$7.03B
$810K 0.01%
+5,602
New +$754K
TGTX icon
514
TG Therapeutics
TGTX
$8.14B
$810K 0.01%
24,379
+9,633
+65% +$287K
HQY icon
515
HealthEquity
HQY
$8.1B
$809K 0.01%
+9,683
New +$794K
TPB icon
516
Turning Point Brands
TPB
$1.53B
$807K 0.01%
+9,303
New +$1.04M
KNSA icon
517
Kiniksa Pharmaceuticals
KNSA
$4.8B
$802K 0.01%
+16,660
New +$738K
UTZ icon
518
Utz Brands
UTZ
$1.25B
$797K 0.01%
+100,598
New +$935K
INSW icon
519
International Seaways
INSW
$4.4B
$790K 0.01%
10,843
+1,994
+23% +$128K
ST icon
520
Sensata Technologies
ST
$6.79B
$787K 0.01%
22,354
+858
+4% +$30.4K
UNP icon
521
Union Pacific
UNP
$174B
$780K 0.01%
3,216
-13,842
-81% -$3.39M
EXPO icon
522
Exponent
EXPO
$2.95B
$778K 0.01%
+11,925
New +$847K
SHC icon
523
Sotera Health
SHC
$4.94B
$776K 0.01%
+54,111
New +$898K
SKYW icon
524
Skywest
SKYW
$3.81B
$772K 0.01%
8,411
-8,481
-50% -$836K
PRI icon
525
Primerica
PRI
$9.71B
$770K 0.01%
3,074
+2,257
+276% +$582K
19 20
21
22 23

Similar funds

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $14.1B AUM 25.71% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Freestone Grove Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Freestone Grove Partners deployed $589M of net new capital in Q1 2026, opening 515 new positions and adding to 214 existing holdings. Its largest new stake was Citigroup: 1,180,436 shares worth $134M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $303M trimmed.

  • Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
  • Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
  • Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
  • Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
  • Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
  • Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
  • Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.